RAC 2.20% $1.78 race oncology ltd

RC220 Phase 1a/b trial - 12-18 months.Cardioprotection & m6A RNA...

  1. 3,809 Posts.
    lightbulb Created with Sketch. 407
    RC220 Phase 1a/b trial - 12-18 months.
    Cardioprotection & m6A RNA phase 2 trial - 18-24 months.
    The plan strategy hasn't changed. 4+ years away.
    Stop the DT retiring after P1 narrative.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.